抗体效价(log2)
; o5 ]' V8 x& P3 L | 攻毒数
& S9 a$ t4 S. B; Z8 K | 死亡数 : n# q1 x; n# ?' c4 N, L+ K
| 存活数 7 J& D4 p1 V0 j( b \
| 保护率%
( l% @/ {5 Z5 s4 c |
03 H, ?% i, z0 p& k6 B: G
| 6
# R: b; U2 L: B | 6
& v" [5 p I& C% J& s) s+ J | 06 O G3 a( `. N( y0 W
| 0
7 Q4 x' S' S2 t |
1
. S" m4 x( u' S( h5 ]1 | | 6
# r/ i; r5 J" H | 6
' Z; @" R6 m& c D* R | 0
2 W( P) Y. x" t. K$ q4 `4 T! K4 z* f | 0
* P5 V; {+ u# Y) r( ]% x |
2
7 T* ]" K" t( v. G8 t, N | 6 ; j' c7 r9 {! k. S
| 3 % U" q/ |* M" }, H6 ?
| 3 8 w& z5 I( ~, U
| 50
3 C! h' n( G7 j |
3
* E: A, ~: ]# X" c | 6 , O' f0 g& Y" c! i- |0 u
| 0
- g2 u, n" R3 ~9 ^* w. D | 6
- C; R: x5 K$ P5 w0 {2 [ | 100 : O- M( m/ h1 M7 R' d0 A
|
4 $ a9 t1 U% n0 U9 v' P
| 6 # r4 Z% ^& _' I* d3 c7 i- `& T
| 0
% A6 p- q! D1 K& t4 s2 {$ p+ { | 6 6 L7 E) V8 w/ G8 K
| 100 , _2 ` q* H% H! y
|
/ Z1 W, t& t# I: i7 x9 Y/ ?
日龄
9 @2 i3 ~& \9 e0 s1 a7 m+ I | ! J% W. R; Z( }/ G6 G( Z+ U- }
免疫后
# V }; n+ `. ^8 D5 X! { |
1周 % M' Y6 T& a; s. v8 @% K
| 2周 ! Z- P! |2 B8 }! b8 q# {
| 3周
/ @7 `) R6 Y1 _5 A6 L4 { | 4周
( ?* j' B$ M" Z, T | 5周
3 v: f( I3 e- c$ k( ]% S& C) ^5 e& e | 6周 9 d5 r+ R- {! z/ @2 d: h4 I
| 7周 / @: t+ W1 H! [) J6 C. w2 \
| 8周
4 f5 s3 w. \0 @- y3 C |
30
/ O& G# o9 g5 z b7 w | 1.67±0.58c
# d4 _8 h4 ?5 {: \! z | 2.75±0.96bc
% W, e$ S7 {8 `+ z3 w9 x | 1.75±0.96b
$ F8 ~$ b7 r) A/ j q: O | 1.00±0.00d
' K3 l+ q8 {# a/ P# n | 0.25±0.50c/ j9 Z/ J6 E, l$ |/ |$ C- F
| 0.13±0.25c
, z; q0 h5 Z/ s6 a& X | 0
5 I, L$ T, Y2 c4 X+ Y4 m( m | 0- _% v% H% u7 i4 y$ D& S1 S% u
|
351 z" s4 L+ S/ f4 K
| 3.25±0.50ab2 c* N" P8 |8 @) p
| 3.00±0.82bc
: _2 l! {" F2 M: H8 A2 Z | 2.38±0.49b
4 @3 t. I2 I# c3 X4 g$ y9 _ | 2.00±0.00c
" I9 Q8 R, r* u9 O | 1.00±0.00c
" M8 s( x, W4 Z+ s% A; I2 l' w# L | 0.75±0.50c' ~6 V! ~! \+ t
| 0* _6 D6 m* S8 C) r; z4 T% P( g
| 08 Y1 a% G* l( k% Y" }% Z
|
40" ~9 Q- z+ J) B# [+ g8 A$ \1 }' H
| 3.00±0.82ab
$ A! G) t5 w1 ]. j9 T% c6 M | 5.75±1.71a3 X5 a9 `! M( g" d/ O' Y6 p
| 5.00±1.83a
# _% W7 E9 ^- _ | 3.25±1.50b5 a5 m9 @8 K/ H5 Q( Q# r7 `
| 3.00±0.82b
+ r2 L5 W! f0 b6 j9 H | 2.13±0.50b
2 u" C6 j3 C: j& P6 d5 o0 p3 | | 1.83±0.58bc
. M$ }+ M( R# c3 V5 D | 1.03±0.63bc2 p- Q( T( x* X8 ]* v
|
45
# [& m& y& W C9 O | 3.25±1.26ab
6 _! [8 k/ S0 K3 J4 n2 L | 4.25±0.96ab
8 \. i; m4 l! b# M; a$ y | 5.50±1.29a# I' g% ^8 {. d2 V7 M! \
| 3.75±0.96b
2 J' u7 x* X3 k6 V/ u | 3.25±1.26b. M7 `% r; i# \6 Y& M5 {* x2 F0 ?9 B
| 2.38±1.80b1 q/ T# I3 v* K
| 2.00±1.41bc
4 @+ r$ }( i# W+ Y4 S+ e | 1.13±0.63bc
7 v; C5 d% J$ ]' M m$ O |
50
/ O- u ?2 `) T. n' K' c | 2.25±0.50bc0 A( e' N: }+ d* m4 M- ^* s
| 4.25±0.96ab. l H: I& {0 y9 Z. d; D
| 4.50±2.08a5 b2 j8 L+ h7 |/ H" y5 {
| 5.75±0.50a
1 t! Q# H( V/ }9 C+ t | 6.00±0.00a
6 A" `; p* B5 J! g | 5.00±0.00a( `3 f- }! t# B9 Z* Y8 p) P
| 3.5±0.58ab
) |( Z* O: B2 \ | 1.50±0.58b: x; h( W' F9 u- z. j8 o! P
|
558 d# }# u8 `( z
| 3.50±0.58a
# j! K* `; J& ^0 J9 N% I. `7 f | 4.75±0.50a
" }% [$ a5 D, i | 6.00±0.82b/ U2 m$ ?, \% A7 K# s2 p
| 5.75±1.50a6 |9 n( L2 i: M2 G3 C
| 5.25±0.96a$ F1 S" S2 G1 a. M# [
| 4.25±0.50a5 G4 y. a# x {* R$ Q) |) \$ N' x
| 3.25±0.96b. M1 n( `3 G# d. K, q
| 2.75±1.26ab
; Y# w5 x' H2 B7 f- i, d. J+ } |
60
) F$ U% q F% A6 I% ~ | 3.50±0.58a, n8 Z6 c7 [7 s) @+ d; t) R, z
| 5.00±0.82a
! t* n1 ~! i# U6 Z$ t q' E | 6.25±0.50a
& F$ I6 a: \! S) B | 5.75±0.96a5 T1 ^+ i9 w, v5 F
| 5.00±0.82a
3 ~' T. D8 N* C u# \# Z1 ^6 X | 4.13±0.85a
/ L( g# Q6 ^2 t; x" R: l& n5 ` | 3.25±0.96b
8 S) B$ i$ q* f4 @* f8 a; o$ y' ? | 2.25±0.96b, u0 _5 W) Z. N1 C/ m- Z& h& \! u" m3 ]
|